Polar Asset Management Partners’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.28M	Buy	91,600 +70,648	+337%	+$988K	0.02%	313
2025 Q1	$285K	Sell	20,952 -530,140	-96%	-$7.21M	0.01%	306
2024 Q4	$11.2M	Buy	551,092 +509,992	+1,241%	+$10.4M	0.13%	125
2024 Q3	$1.2M	Buy	41,100 +17,000	+71%	+$495K	0.03%	375
2024 Q2	$560K	Buy	+24,100	New	+$560K	0.01%	401